Christine Flashcards

1
Q

Molecular signalling

A

The transmission of information, often from the external surface of a cell to the nucleus
Determines the biological output after the activation/engagement of receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do cells signal?

A

Activation of intracellular proteins
Activation of second messengers
Protein-protein interactions
Enzymatic cascades

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mechanisms of signal transmittance

A

Conformational coupling (pre-formed complex) e.g. channels, receptors
Conformational coupling (diffusion-dependent complex formation) e.g. cAMP, cGMP, Ca, proteins
Post-translational modifications e.g. phosphorylation, acetylation, oxidation
Protein degradation e.g. ubiquitin-proteasome, proteases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How are signals measured?

A

Enzyme activity
Changes in gene expression
Fluorescent probe e.g. Ca mobilisation, phosphoinositides
Measure phosphorylated substances (Ab-based methods) e.g. immunoblotting, ELISA, flow cytometry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Key features of molecular signalling

A

Specificity (of response)
Coordination (of signals)
Location (within the cell)
Regulation (signal must be down-regulated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Protein interaction domains

A

Sequence- and structural-specific regions within proteins that enable them to bind to/interact with other cellular molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SH2

A

Src homology 2 domain
Binds to phosphotyrosine residues via a ‘positively-charged pocket’
100 AA
Present in a diverse range of cytosolic proteins
High “off” rate - interactions are dynamic, rapid on/off
Has an extended surface that binds to residues at the C-terminal of the phosphotyrosine - variability in the AA sequence of this determines specificity
e.g. Src SH2 binds to pYEEI, Grb2 SH2 binds to pYVNV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PTB

A

Phosphotyrosine binding domain
Present in scaffolding proteins e.g. Shc, IRS, FRS2
Originally thought to bind NPXpY units, but Shc PTB can also bind to PIP2 and FRS2 PTB can bind to a non-phosphorylated FGFR ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

14-3-3

A

Binds to phosphoserine
Dimer
Important in the regulation of DNA repair and apoptosis (can bind to Bad)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

WD40

A

Involved in ubiquitination/degradation pathways and G1 to S phase transition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

FHA

A

Forkhead-associated domain
Binds to phosphothreonine (pTXXD motif)
Important in DNA repair and protein trafficking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SH3

A
Src homology 3 domain
Binds to proline-rich motifs e.g. XPnXP, where is a hydrophobic AA)
50 AA
3 pocket structure
Constitutive binding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

WW

A

Binds to proline-rich motifs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

EVHI

A

Binds to proline-rich motifs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PH

A

Pleckstrin homology domain
Binds to phospholipids/phosphoinositides e.g. PIP2, PIP3
“Protein-lipid interaction”
120 AA
Present in scaffolding proteins e.g. Gab, PKB, PDK1, kinases
Enables specific recruitment to the membrane
3 variable loops, positively charged surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

PDZ

A

Primarily involved in anchoring receptor proteins to the cytoplasm - plays a role in localising cellular elements
Binds to the C-terminals of target proteins via a specific motif

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

FYVE

A

Bind to PIP3

Regulate membrane traffic in endosomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

PX

A

Bind to phosphoinositides and SH3 domains

Diverse function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

FRET

A

Fluorescence Resonance Energy Transfer
A mechanism describing the energy transfer between 2 light sensitive molecules
A donor fluorophore (in its electronically excited state) may transfer energy to an acceptor fluorophore through non-radiative dipole-dipole coupling
The efficiency of this energy transfer is inversely proportional to the 6th power of the distance between the fluorophores
Measurement of FRET efficiency can be used to determine if 2 fluorophores are within a certain distance of one another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Roles of protein phosphorylation

A

Control enzyme activity e.g. by changing enzyme conformation
Regulate interactions between proteins
Control protein localisation within the cell
Initiation, regulation and coordination of signalling pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

JAK1 knockout

A

Perinatal lethality caused by impaired lymphopoiesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

JAK2 knockout

A

Embryonically lethal (no erythropoiesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

JAK3 knockout

A

SCID (same as no common gamma chain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

STAT1 in cancer

A

Involved in IFNy response to infection
Tumour suppressor
STAT1 KO = no immune response, no apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

STAT3 in cancer

A

Required for the self-renewal of ESCs (recruited by LIF binding). KO = embryonically lethal
Constitutively active in many tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

STAT5 in cancer

A

Regulates apoptosis, promotes proliferation and cell cycle progression
Mediator of BCR-Abl signalling - higher STAT5 levels seen in CML cells
Constitutively phosphorylated/active in cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

SOCS1-/- mice

A

Runted, die within 3 weeks due to liver degeneration
Similar phenotype to mice that overexpress IFNy - because no SOCS1 = excessive IFNy, STAT1/6, IL-4 signalling
Blocking IFNy or cross IFNy-/- mice with SOCS1-/- mice prevents disease

28
Q

SOCS2-/- mice

A

Increased growth

Because SOCS2 negatively regulates cytokine receptors that drive growth

29
Q

SOCS3-/- mice

A

Too many RBCs

SOCS3 regulates erythropoiesis

30
Q

CIS-/- mice

A

Normal

31
Q

SHP1

A

PTPN6

32
Q

SHP2

A

PTPN11

33
Q

Tetracycline-controlled transcriptional activation

A

A method of inducible gene expression, where transcription is reversibly turned on or off in the presence of tetracycline

34
Q

Difference between Tet-Off and Tet-On inducible expression systems

A

Difference relates to their respective responses to tetracycline (not whether the transactivator turns a gene on or off)
Tet-Off induces expression in the absence of tetracycline
Tet-On induces expression in the presence of tetracycline

35
Q

Plasmid system in tetracycline-controlled transcriptional activation

A

2 plasmid system
Plasmid 1 = contains CMV promoter and TTa gene
Plasmid 2 = contains TTa-dependent promoter and gene of interest

36
Q

CMV promoter

A

Strong promoter, drives the constitutive expression of genes under its control

37
Q

TTa

A

Tetracycline transactivator protein

38
Q

TTa-dependent promoter

A

What TTa binds to
Tet-Off system = TTa can only bind if it is not bound to tetracycline
Tet-On system = TTa can only bind if it is bound to tetracycline

39
Q

Mechanism of JAK/STAT inhibition by SOCS1

A

Binds to JAKs to inhibit their catalytic activity

40
Q

Mechanism of JAK/STAT inhibition by SOCS3/CIS

A

Bind to cytokine receptors and block their association with other proteins

41
Q

Mechanism of JAK/STAT inhibition by SOCS in general

A

Increase receptor degradation through recruitment of E3 ubiquitin ligase via SOCS box domain
Bind to other signalling proteins e.g. IRS1

42
Q

Yeast two-hybrid

A

Protein interaction technology
A protein-fragment complementation assay, a method for the identification and quantification of protein-protein interactions

43
Q

What is the premise behind the yeast two-hybrid assay?

A

The transcription of the reporter gene (GFP) relies on the binding of a TF to an UAS
Y2H relies on the fact that most eukaryotic TFs are modular - they can be split into 2 parts and reconstituted non-covalently to form a functional TF
However, the 2 fragments have low affinity for one another and must be brought together by interacting to which they are fused

44
Q

Y2H method

A

TF split into 2 fragments:
1. DNA-binding domain (fused to target protein)
2. Activating domain (fused to potential binding partner of target protein)
The fragments are introduced into yeast cells
If the 2 proteins interact with one another, they will bring the BD and AD of the TF into close proximity, forming a functional transcriptional unit and activating/initiating transcription of the reporter gene

45
Q

Protein microarrays

A

Can track large numbers of proteins in parallel
Highly sensitive
Automated

46
Q

Similarities and differences between growth factor and cytokine receptors

A
Receptor chains
Ligand
Activation
Signalling molecule recruitment
Changes in disease
47
Q

Ligand-induced activation of RTKs/cytokine receptors

A

The cytosolic domain of RTKs contains a protein tyrosine kinase catalytic site, whereas the cytosolic domain of cytokine receptors is closely associated with a separate JAK
In both types of receptor, ligand binding causes a conformational change that promotes dimerisation, bringing together the intrinsic (RTK)/associated (cytokine) kinases
The kinases phosphorylate each other on a Tyr residue in the activation lip, causing the lip to move out of the kinase catalytic site and allowing ATP/a protein substrate to bind
Activated kinase then phosphorylates other Tyr residues in the receptor’s cytosolic domain
The resulting phosphotyrosines function as docking sites for signal transduction proteins with SH2/PTB domains

48
Q

Structure of JAKs

A

H2N-receptor binding-pseudo kinase-kinase-COOH

49
Q

Deletion of JAK pseudo kinase domain

A

Affects JAK function but currently unsure what the actual function of the domain is

50
Q

How is the specificity of the JAK/STAT pathway determined?

A

Multiple cytokines activate the same JAK

The specificity of the response is determined by receptor recruitment of STATs

51
Q

Mutations in JAK1/Tyk2

A

No response to IFNa/b

52
Q

Mutations in JAK1/JAK2

A

No response to IFNy

53
Q

JAK expression profiles

A

Jak1, Jak2, Tyk2 = ubiquitous

Jak3 = restricted expression to WBCs

54
Q

Ser/Thr kinases

A

5 major families

Main families = MAPK, PKB

55
Q

MAPK

A

Mitogen-activated protein kinases
e.g. ERK1/2, JNK, p38
Evolutionarily conserved
Part of phosphorelay system where a series of 3 protein kinases phosphorylate and activate one another (Raf –> MEK –> ERK)
Activated by dual phosphorylation of Thr and Tyr
“Proline-directed kinases” - phosphorylate PXS and TP motifs

56
Q

Tyrosine phosphatases

A

Can be positive and negative regulators of molecular signalling
2 classes - transmembrane and cytoplasmic

57
Q

Common features of tyrosine phosphatases

A

Phosphotyrosine-specific phosphohydrolase activity
Conserved active site motif containing:
Cys - required for catalysis, nucleophilic attack on P to remove phosphate group
Asp - protonates reformed Tyr group after loss of phosphate
Arg - stabilises pY in pocket so reaction can occur

58
Q

Insulin receptor

A

RTK

59
Q

Insulin receptor pathway

A

Phosphorylation of receptor Tyr residues generates a binding site for IRS that are then activated by phosphorylation
Activated IRS1 can bind to/activate PI3K and Shc/Grb2
Both of these pathways lead to glucose/lipid metabolism

60
Q

How is the insulin signalling pathway switched off?

A

By PTP1B

PTP1B also regulates leptin signalling

61
Q

Leptin

A

Hunger hormone (inhibits hunger, generates feeling of satiety)
Signals through JAK2/STAT3
Leptin-activated JAK2 is a substrate for PTP1B

62
Q

SHP structure

A

2 tandem SH2 domains in N-terminus follows by a PTP domain
SHP kept inactive by intramolecular binding of N-terminal SH2 to PTP domain (auto-inhibition)
Inhibition relieved by binding of SH2 domain to a pY

63
Q

Moth-eaten mice

A

Moth-eaten appearance as a result of spontaneous mutation in SHP-1 gene
Mice die with 3 weeks of birth due to pneumonitis (lung inflammation due to massive macrophage infiltration)
SHP-1 involved in regulation of STAT5 signalling

64
Q

Discovering SHP-1 substrates

A

Use substrate-trapping mutants - want to bind substrate and phosphatase for long enough so that complex can be coimmunoprecipitated
Cys –> Ser = no nucleophilic attack, catalytically dead, substrate is trapped
Asp –> Ala = no protonation of leaving group so cannot dissociate, catalytically dead, substrate trapping
Arg –> Met = substrate not stabilised in pocket

65
Q

Catalytically inactive SHP-1

A

Increases IL-3-mediated cellular growth

66
Q

SHP-2

A

Dual function: phosphatase and adaptor molecule with no phosphatase activity

67
Q

Investigating catalytic activity of SHP-2

A

Cys –> Ser mutant is catalytically inactive and substrate trapping, reduces activation of MAPKs by many stimuli
It is believed that SHP-2 acts as an adaptor molecule to activate the pathway then dissociates and carries out its phosphatase activity to down-regulate the pathway